Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.
Published

Preclinical evaluation of psilocybin and related compounds: Inhibition of cytochrome P450 isoforms

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal
RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia
Date
2026-05-01
Source
Crossref
DOI
10.51126/revsalus.v8isupii.46635
PubMed
Unavailable

Authors

Mariana Silva-CarvalhoAndreia Machado Brito-da-CostaRicardo Dinis-OliveiraÁurea Madureira-CarvalhoDiana Dias-da-Silva
Watch author

Derived topics and classifications

psilocybin Animal Study Animal Study

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Preclinical evaluation of psilocybin and related compounds: Inhibition of cytochrome P450 isoforms2026-05-01

Related papers

Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophreniaNeuropsychopharmacology · 2026-07-18From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-10Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric DisordersPsychiatry and Clinical Psychopharmacology · 2026-03-30Psychedelics produce enduring enhancement of reward responsiveness in male rats.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-07-10Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’Behavioural Pharmacology · 2026-05-06Evaluating the evidence for repressed memory recovery in psychedelic contextsPsychopharmacology · 2026-04-28Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative reviewClinical Neuropsychopharmacology and Addiction · 2025-09-24